Updating the French method for the causality assessment of adverse drug reactions.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  The´rapie (Paris)

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2515/therapie/2013016PMID 23773347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recent changes in vancomycin use in renal failure.

  2010cited by this paper
• Comparison of Three Methods (Consensual Expert Judgement), (Algorithmic and Probabilistic Approaches) of Causality Assessment of Adverse Drug Reactions

  2010cited by this paper
• Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems.

  2009cited by this paper
• Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

  2008cited by this paper
• Prospective screening for human leukocyte antigen-B*5701 avoids abacavir hypersensitivity reaction in the ethnically mixed French HIV population.

  2007cited by this paper
• Acetaminophen‐induced acute liver failure: Results of a United States multicenter, prospective study

  2005cited by this paper
• Glucose-6-phosphate dehydrogenase deficiency.

  1991cited by this paper
• Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France

  1985cited by this paper
• [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].

  1985cited by this paper
• Imputabilité des effets indésirables des médicaments.

  1982cited by this paper
• [Mehtod for determination of undesirable effects of drugs].

  1978cited by this paper

• Health risks associated with non-medical use of ketamine in France: National surveillance insights from the French Addictovigilance Network, 2019-2023.

  2026cites this paper
• Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes

  2026cites this paper
• Cerebral air embolism induced by polidocanol foam sclerotherapy in chronic venous disease: A case report.

  2025cites this paper
• Allergological work-up of severe cutaneous adverse reactions with suspicion of anxiolytics or sleeping pills. A multicenter retrospective study of 20 cases.

  2025cites this paper
• Hydroxyurea-induced severe interstitial pneumonitis: A case report.

  2025cites this paper
• Assessment of adverse drug reactions encountered in primary care settings

  2025cites this paper
• Fluoxetine-induced lower limb ecchymosis in an adolescent: A case report and literature review.

  2025cites this paper
• Progressive outer retinal necrosis complicating aseptic meningitis due to varicella zoster virus reactivation 44 days after infusion of natalizumab.

  2025cites this paper
• Drug Provocation Testing in Allergological Work‐Up of DRESS: A Retrospective Real‐Life Experience From a Specialist Centre

  2025cites this paper
• Evaluation of the reproducibility and validity of the use of the causality assessment method for poisonings designed and applied by the French poison control centres

  2025cites this paper
• Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease.

  2025cites this paper
• Retinal venous occlusion in drug-induced lupus.

  2025cites this paper
• Can large language models detect drug–drug interactions leading to adverse drug reactions?

  2025cites this paper
• Case report: Spontaneous splenic rupture concomitant with serum sickness induced by infliximab.

  2025cites this paper
• Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention: The URGEIM Randomized Clinical Trial.

  2025cites this paper
• Methylphenidate-associated eosinophilia in a child: A case report.

  2025cites this paper
• Photodistributed cutaneous vasculitis: An uncommon side effect for topical ketoprofen.

  2025cites this paper
• Encephalopathy associated with equimolar mixture of oxygen and nitrous oxide (EMONO) abuse: A case report.

  2025cites this paper
• TNF Inhibitor‐Induced Sarcoidosis‐Like Lesions in Inflammatory Bowel Disease

  2025cites this paper
• Disseminated Mycobacterial Infection With Reactive Polyarthritis (Poncet’s Disease) During Immune-suppressive Treatment Including Ustekinumab for Pediatric Crohn’s Disease

  2024cites this paper
• BABINE: An original and user-friendly scale for the simple and quick management of herb-drug interactions in clinical practice

  2024cites this paper
• An Uncommon Case of DRESS Syndrome Induced by Potaba With a Positive Patch Test.

  2024cites this paper
• Patch tests in non‐immediate cutaneous adverse drug reactions: Late readings on Day 4 is more sensitive than on Day 3

  2024cites this paper
• Dapagliflozin-induced leukocytoclastic vasculitis.

  2024cites this paper
• Reply.

  2024cites this paper
• Linear IgA Bullous Dermatosis in Korea Using the Nationwide Health Insurance Database

  2024cites this paper
• Terbinafine induced bullous pemphigoid.

  2024cites this paper
• Involvement of Pharmacists in the Emergency Department to Correct Errors in the Medication History and the Impact on Adverse Drug Event Detection

  2023cites this paper
• Nivolumab Safety in Renal Cell Carcinoma: A Case Report

  2023cites this paper
• Kidney Function Decline and Serious Adverse Drug Reactions in Patients With CKD.

  2023cites this paper
• Drug-induced uveitis related to Checkpoint inhibitors and MAPkinase inhibitors.

  2023cites this paper
• Acute stroke in patients taking an oral anticoagulant: impact of clinical pharmacist’s intervention on pharmacovigilance reporting

  2023cites this paper
• Carbamazepine-induced bullous fixed drug eruption: A case report.

  2023cites this paper
• Drug-related hypophosphatemia: Descriptive study and case/non-case analysis of the French national pharmacovigilance database.

  2023cites this paper
• Acute generalized exanthematous pustulosis induced by duloxetine

  2023cites this paper
• Which Adverse Events and Which Drugs Are Implicated in Drug-Related Hospital Admissions? A Systematic Review and Meta-Analysis

  2023cites this paper
• Prise en charge des toxidermies graves induites par les antidépresseurs et les antipsychotiques. Comment les prendre en charge ?

  2022cites this paper
• Psoriasis exacerbation associated with bupropion-induced exanthema.

  2022cites this paper
• Beware of Rhabdomyolysis After a Renal Graft

  2022cites this paper
• Frequency, Characteristics, and Predictive Factors of Adverse Drug Events in an Adult Emergency Department according to Age: A Cross-Sectional Study

  2022cites this paper
• Shortcomings of Administrative Data to Derive Preventive Strategies for Inhospital Drug-Induced Acute Kidney Failure—Insights from Patient Record Analysis

  2022influential citation
• Toward Kidney-Specific Causality Assessment Tool.

  2022cites this paper
• Organisation et intérêt de la pharmacovigilance

  2022cites this paper
• Indication et réalisation des tests allergologiques dans les hypersensibilités retardées médicamenteuses de l’adulte

  2021cites this paper
• Impact of medication characteristics and adverse drug events on hospital admission after an emergency department visit: Prospective cohort study

  2021cites this paper
• Potential Cytochrome P450-mediated pharmacokinetic interactions between herbs, food, and dietary supplements and cancer treatments.

  2021cites this paper
• Prise en charge d’un exanthème maculo-papuleux

  2021cites this paper
• Serious Neurological Adverse Events of Ceftriaxone

  2021cites this paper
• Bullous haemorrhagic dermatitis induced by heparins and other anticoagulants: 94 cases from French pharmacovigilance centres and a literature review.

  2021cites this paper
• Idiopathic non-cirrhotic portal hypertension (INCPH) during azathioprine treatment in patient with Crohn's disease: A case report.

  2021cites this paper
• Patch tests in nonimmediate cutaneous adverse drug reactions: The importance of late readings on day 4

  2021cites this paper
• Psychotic Episode following Treatment with Hydroxychloroquine in a 17- Year-Old Female Adolescent with Cutaneous Lupus Erythematosus: A Drug Causality Supported by a Literature Review and a Worldwide Pharmacovigilance Database Search

  2021cites this paper
• Adverse Drug Events Detected by Clinical Pharmacists in an Emergency Department: A Prospective Monocentric Observational Study

  2020cites this paper
• Preconceived notions about biosimilars—a French experience

  2020cites this paper
• Polyarthralgies migratrices induites par le fumarate de diméthyle

  2020cites this paper
• Severe poisoning with naproxen causing coagulopathy

  2019cites this paper
• An update on the management of severe cutaneous drug hypersensitivity reactions.

  2019cites this paper
• Acute exanthemas: a prospective study of 98 adult patients with an emphasis on cytokinic and metagenomic investigation

  2019cites this paper
• Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases

  2019cites this paper
• Re‐exploring immune‐related side effects of docetaxel in an observational study: Blood hypereosinophilia

  2019cites this paper
• [Delayed hypersensitivity to anti-tuberculosis drugs. Proposed practical management plan for exanthema: when to stop, which allergological investigations to perform, and how to restart treatment].

  2019cites this paper
• Dimethyl fumarate induced migrating polyarthralgias.

  2019cites this paper
• Effet indésirable rare d’un anti-IL-1RA

  2019cites this paper
• Pharmacovigilance - The next chapter.

  2019cites this paper
• Psoriasis After Exposure to Angiotensin-Converting Enzyme Inhibitors: French Pharmacovigilance Data and Review of the Literature

  2019cites this paper
• [Prevalence of hydroxychloroquine-induced side-effects in dermatology patients: A retrospective survey of 102 patients].

  2018cites this paper
• Immediate-Type Hypersensitivity Cross-Reactions to Proton Pump Inhibitors: A Descriptive Study of Data from the French National Pharmacovigilance Database

  2018cites this paper
• Three case reports of involuntary muscular movements as adverse reactions to sacubitril/valsartan

  2018cites this paper
• PS-073 Patient records analysis for potentially preventable adverse drug events leading to acute kidney injury following a propensity matched cohort study

  2017cites this paper
• Vascularite cutanée induite par l’amiodarone

  2017cites this paper
• Cyamémazine (Tercian®) et syndromes extrapyramidaux : exploration des cas contenus dans la base nationale de pharmacovigilance

  2017cites this paper
• Polymyosite éosinophilique liée à l’utilisation du fébuxostat dans le traitement d’un lymphome de la zone marginale

  2017cites this paper
• Décès imputables aux médicaments : analyse rétrospective au CHU de Grenoble-Alpes en 2014

  2017influential citation
• PS-071 A new semi-automatic tool for assessing treatment prescribing based on real time blood tests

  2017cites this paper
• [Amiodarone-induced immune complex cutaneous vasculitis].

  2017cites this paper
• Febuxostat-associated eosinophilic polymyositis in marginal zone lymphoma.

  2017cites this paper
• [Cyamemazine (Tercian®): Exploration of extrapyramidal syndrome cases contained in the French pharmacovigilance database].

  2017cites this paper
• Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting

  2017cites this paper
• [Pseudo-pheochromocytoma due to iproniazid: A case report].

  2016cites this paper
• Which pharmacovigilance for vaccines?

  2016cites this paper
• Fatal Kounis syndrome with stent thrombosis secondary to amoxicillin/clavulanic acid use: A case report and literature review.

  2016cites this paper
• [Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system].

  2016cites this paper
• Three Complementary Approaches to Characterize Buprenorphine Misuse

  2016cites this paper
• Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir.

  2016cites this paper
• Causality assessment in pharmacovigilance: The French method and its successive updates.

  2016cites this paper
• Can an early diagnostic procedure of metformin-associated lactic acidosis in an emergency unit reduce mortality?

  2016cites this paper
• Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database

  2016cites this paper
• Imputabilité en pharmacovigilance : de la méthode française originelle aux méthodes réactualisées

  2016cites this paper
• Causality assessment in reports on adverse drug reactions. Algorithm of Spanish pharmacovigilance system

  2016cites this paper
• [Hospital readmission induced by adverse drug reaction: a pilot study in a post-emergency unit of a French university hospital].

  2015cites this paper
• Development and Application of Network Toxicology in Safety Research of Chinese Materia Medica

  2015cites this paper
• The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project

  2015cites this paper
• Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies.

  2015cites this paper
• A digestive allergic reaction with hypereosinophilia imputable to docetaxel in a breast cancer patient: a case report

  2015cites this paper
• Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems

  2014cites this paper
• [Not Available].

  2014cites this paper
• [Gabapentin-induced cutaneous leukocytoclastic vasculitis].

  2014cites this paper
• Imiquimod and pulmonary embolism: a case report.

  2014cites this paper
• Drug, Healthcare and Patient Safety Dovepress

  year unknowncites this paper